{
  "ptid_time": "033_S_1309_2008-08-27",
  "img_path": "/data/qiuhui/data/adni/images/033_S_1309/2008-08-27/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 37,444 mm³, 33.4% above the reference mean. With a Z-score of 0.76 (77.8th percentile), this represents normal volume ; hippocampal volume measures 5,168 mm³, 27.4% below the reference mean. With a Z-score of -2.51 (0.6th percentile), this represents significant atrophy; whole brain volume measures 1,011,810 mm³, 3.8% above the reference mean. With a Z-score of 0.48 (68.4th percentile), this represents normal volume ; entorhinal cortex volume measures 2,378 mm³, 35.3% below the reference mean. With a Z-score of -2.16 (1.5th percentile), this represents significant atrophy; fusiform gyrus volume measures 18,310 mm³, 7.6% above the reference mean. With a Z-score of 0.69 (75.6th percentile), this represents normal volume ; middle temporal gyrus volume measures 18,152 mm³, 5.3% below the reference mean. With a Z-score of -0.46 (32.2th percentile), this represents normal volume . ",
  "text_data": "Age is 70.6 years. Gender is Female. Education: 16 years. MMSE: 28.0. APOEε4 alleles: 2.0. ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant atrophy in the hippocampus (Z-score -2.51) and entorhinal cortex (Z-score -2.16), both critical regions for memory and early Alzheimer's pathology. Despite normal MMSE (28/30) and preserved whole-brain volume, the severe atrophy in these regions suggests neurodegeneration consistent with early-stage Alzheimer’s. The presence of two APOE4 alleles further increases risk.  \n\n**Diagnosis:** **MCI (likely due to Alzheimer’s pathology)**  \n**Confidence:** **Medium** (High confidence in neurodegeneration, but MCI diagnosis is provisional without longitudinal cognitive decline or biomarker confirmation (e.g., amyloid PET/CSF). MMSE is insensitive to early MCI.)  \n\n---  \n*Key points:*  \n- **Hippocampal/entorhinal atrophy** is a hallmark of Alzheimer’s, even with normal MMSE.  \n- **APOE4 homozygosity** greatly elevates AD risk.  \n- **Next steps:** Amyloid/tau biomarkers or follow-up cognitive testing to confirm progression.",
  "timestamp": "2025-07-26T05:35:08.879332"
}